Patent number: 4755323
Abstract: New 1,4-dioxanes of the formula I ##STR1## wherein R.sup.1 and R.sup.2 each signify and alkyl group with 1 - 10 C-atoms, wherein one or two CH.sub.2 groups can also be replaced by O-atoms, F, Cl, Br or CN,R.sup.2 also H,A.sup.1 and A.sup.2 each signify 1,4-phenylene, 1,4-cyclohexylene, 1,3-dioxane-2,5-diyl, 1,4-dioxane-2,5-diyl, peperidine-1,4-diyl, 1,4-bicyclo(2,2,2)-octylene or pyrimidine-2,5-diyl groups, unsubstituted or substituted by 1 - 4 F-atoms,Z.sup.1 and Z.sup.2 each signify --CO--O--, --O--CO--, CH.sub.2 CH.sub.2 --, OCH.sub.2 -- --CH.sub.2 O-- or a single bond,m and n each signify 0, 1, 2 or 3,(m+n), however, are at least 1 and at most 3,whereby for m=2 or 3, the groups A.sup.1 and for n=2 or 3 the groups A.sup.2 can each be the same or different from one another,as well as the acid-addition salts of the basic ones of these compounds,are suitable for use as components of liquid-crystalline dielectrics.
Type:
Grant
Filed:
March 13, 1986
Date of Patent:
July 5, 1988
Assignee:
Merck Patent Gesellschaft mit beschrankter Haftung
Inventors:
Rudolf Eidenschink, Georg Weber
Patent number: 4642373
Abstract: 1,2,3,4,4a,4b,5,6,7,8,8a,12b-Dodecahydro-7-(oxo, hydroxy or amino)-9-hydroxy-11-(alkyl, alkoxy or alkoxyalkyl)triphenylenes, 2,3,3a,3b,4,5,6,7,7a,11b-decahydro-6-(oxo, hydroxy or amino)-8-hydroxy-10-(alkyl, alkoxy or alkoxyalkyl)-1H-cyclopenta[1]-phenanthrenes, 2,3,4,4a,4b,5,6,7,8,8a-decahydro-7-(oxo, hydroxy or amino)-9-hydroxy-11-(alkyl, alkoxy, alkoxyalkyl, aralkyl, aralkoxy, aryloxyalkyl or aralkoxyalkyl)-1H-pyrido[1,2-f]phenanthridines, and 1,2,3,3a,3b,4,5,6,7,7a-decahydro-6-(oxo, hydroxy or amino)-8-hydroxy-10-(alkyl, alkoxy or alkoxyalkyl)pyrrolo[1,2-f]phenanthridines and derivatives are valuable as central nervous system active agents or as intermediates to compounds having such activity.
Type:
Grant
Filed:
July 6, 1984
Date of Patent:
February 10, 1987
Assignee:
Pfizer Inc.
Inventors:
James F. Eggler, Michael R. Johnson, Lawrence S. Melvin, Jr.
Patent number: 4473704
Abstract: 1,2,3,4,4a,4b,5,6,7,8,8a,12b-Dodecahydro-7-(oxo, hydroxy or amino)-9-hydroxy-11-(alkyl, alkoxy or alkoxyalkyl)triphenylenes, 2,3,3a,3b,4,5,6,7,7a,11b-decahydro-6-(oxo, hydroxy or amino)-8-hydroxy-10-(alkyl, alkoxy or alkoxyalkyl)-1H-cyclopenta[1]phenanthrenes, 2,3,4,4a,4b,5,6,7,8,8a-decahydro-7-(oxo, hydroxy or amino)-9-hydroxy-11-(alkyl, alkoxy, alkoxyalkyl, aralkyl, aralkoxy, aryloxyalkyl or aralkoxyalkyl)-1H-pyrido[1,2-f]phenanthridines, and 1,2,3,3a,3b,4,5,6,7,7a-decahydro-6-(oxo, hydroxy or amino)-8-hydroxy-10-(alkyl, alkoxy or alkoxyalkyl)pyrrolo[1,2-f]phenanthridines and derivatives are valuable as central nervous system active agents or as intermediates to compounds having such activity.
Type:
Grant
Filed:
March 16, 1982
Date of Patent:
September 25, 1984
Assignee:
Pfizer Inc.
Inventors:
James F. Eggler, Michael R. Johnson, Lawrence S. Melvin, Jr.